Untitled Document
www.expresshealthcare.in INSIGHT INTO THE BUSINESS OF HEALTHCARE
August 2010  
Untitled Document
Sections

Market
Medicall 2010
Strategy
Knowledge
Healthcare@Orissa
Trade & Trends
Healthcare Life

Specials

In Imaging
Criticare Frontiers 2009

Services
Subscribe/Renew
Archives
Search
Contact Us
Network Sites
Express Computer
Exp. Channel Business
Express Hospitality
Express TravelWorld
Express Pharma
Group Sites
ExpressIndia
Indian Express
Financial Express

Home - Market - Article

Research

Pre-eclampsia Risk for Women with Type 1 Diabetes Unaffected by Vitamin C & E Supplements

The report also suggest that vitamin supplementation could be beneficial in those women with low levels of dietary antioxidants in their blood

A new report published by medical journal The Lancet, reveals women with type 1 diabetes, who are at high risk of pre-eclampsia and preterm delivery, will not have their risk lowered by taking vitamin supplements C and E. The report, involving researchers from the Centre for Public Health and the School of Nursing and Midwifery at Queen's University Belfast and the Belfast Health and Social Care Trust also found, however, that vitamin supplementation could be beneficial in those women with low levels of dietary antioxidants in their blood and that this possibility needs further investigation.

The causes of pre-eclampsia are not known, but it has been suggested that oxidative stress, (where free radicals harm cells), might play a key role in the development of the condition. In 1999, a small trial suggested that vitamin C and E might reduce pre-eclampsia in all pregnant women, not just those with type 1 diabetes. Since then, however, subsequent larger trials found no benefit of vitamin C and E supplementation during regular pregnancies.

Several previous research studies had also previously suggested that because type 1 diabetes is associated with both increased oxidative stress (and a reduction in antioxidants), antioxidant vitamin supplements could improve outcomes for these women. To investigate further, the Diabetes and Pre-Eclampsia Intervention Trial (DAPIT) study group examined the benefits of 1000 mg vitamin C and 400 IU (international units) vitamin E in 762 pregnant women with type 1 diabetes, recruited from 25 UK antenatal clinics in the UK. Women were randomly assigned to vitamins (379) or placebo (383) daily from between 8 and 22 weeks until delivery.

Overall, findings showed that the rate of pre-eclampsia was similar in both groups (15 per cent vs 19 per cent). In women with low antioxidant status at the start of the study however, taking vitamins was associated with a significantly lower risk of pre-eclampsia.

There was no evidence of harm from vitamin supplementation to either mothers or babies. Antioxidant vitamins did not increase the likelihood of developing high blood pressure during pregnancy (11 per cent vs 11 per cent) and actually tended to reduce the risk of having a low birthweight baby (six per cent vs 10 per cent). Additionally, fewer babies were born preterm to women taking vitamin C.

Professor Ian Young from the Centre for Public Health, Queen's School of Medicine, Dentistry and Biomedical Sciences, said, "Dietary intervention rich in various antioxidants might have benefits that cannot be replicated by individual supplements. Alternatively, prescription of antioxidant vitamins at 8-22 weeks' gestation might be too late to affect the pathological process for most patients with diabetes.

"In principle, the notion that oxidative stress is implicated in the cause and development of pre-eclampsia remains plausible, but the benefit of vitamin supplementation might be limited to women with vitamin depletion; however, this idea needs confirmation."

Baha M Sibai from the University of Cincinnati, Ohio, USA, said, "The causes of pre-eclampsia might be multi-factorial. Some cases might be caused by immunological factors, others by dietary factors, and others because of pre-existing medical conditions, or by a combination of these factors. Therefore any single intervention is unlikely to be effective in prevention."

EH News Bureau

 


Untitled Document

FEEDBACK: We would love to hear from you -- what you like about our content, what you dont, and even how you think we can improve. Please send your feedback to: healthcare@expressindia.com


© Copyright 2001: The Indian Express Limited. All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of The Indian Express Limited. Site managed by BPD.